The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently held their Annual Meeting (18–22 May, New Orleans, LA, USA) which focused on disruption and innovation in health economics and outcomes research (HEOR). The meeting, which welcomed attendees from health policy, public and private payers, healthcare providers, patient organizations and academicians, had an expansive program covering case studies, recent innovations and areas for improvement.
A key theme this year was ‘disruption’, with the first plenary, as well as other sessions, covering new technology and the need for adaptive thinking. Points raised in various discussions included the need to focus on what technology was benefiting patients, avoiding ‘hype’ and what actually constitutes innovation.
Thx to #ISPORannual for great panel on disruptive health tech! Exciting things happening, but need to make sure HYPE does not distract from the science-informed basics! @PeterNeumann11 @ISPORorg @ColleenFlood2 @DrMJoyner
See: "Why Science Hype Matters" https://t.co/YVck3Gr8wC pic.twitter.com/JqWpJUu8II
— Timothy Caulfield (@CaulfieldTim) May 20, 2019
The need for transparency and patient involvement was also highlighted, including transparent pricing, health technology assessments (HTA) and definitions of value. Patient organizations were vocal, discussing what patients want for a therapy and how key stakeholders such as payers can balance affordability versus value.
Excellent advice to medical device companies from Stephen A Hull of Hull Associates. Companies need to go beyond requirements of regulators and better understand the needs of payers. #ISPORannual pic.twitter.com/ZoNDkmTarR
— Brian O'Rourke (@ORourke_B) May 21, 2019
ISPOR CEO and Executive Director Nancy S. Berg commented, “Our ISPOR 2019 annual conference convened HEOR leaders from around the world to discuss the new emerging era in health economics and outcomes research and to reimagine HEOR. The focus on disruption and innovation in the field will help shape the future of HEOR and aligns with the Society’s mission to improve healthcare decisions.”